Sage Journals: Discover world-class research

Abstract

In HIV vaccine efficacy trials, mark-specific hazards models have important applications and can be used to evaluate the strain-specific vaccine efficacy. Additive hazards models have been widely used in practice, especially when continuous covariates are present. In this article, we conduct variable selection for a mark-specific additive hazards model. The proposed method is based on an estimating equation with the first derivative of the adaptive LASSO penalty function. The asymptotic properties of the resulting estimators are established. The finite sample behavior of the proposed estimators is evaluated through simulation studies, and an application to a dataset from the first HIV vaccine efficacy trial is provided.

Keywords

Adaptive LASSO additive hazards model competing risks continuous mark mark-specific vaccine effects survival data

Get full access to this article

View all access options for this article.

References

Gilbert

Mckeague

Sun

Tests for comparing mark-specific hazards and cumulative incidence functions. Lifetime Data Anal 2004; 10: 5–28.

Gilbert

Mckeague

Sun

The two-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy. Biostatistics 2008; 9: 263–276.

Sun

Gilbert

Mckeague

IW.

Proportional hazards models with continuous marks. Ann Stat 2009; 37: 394–426.

Sun

Gilbert

PB.

Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials. Biostatistics 2013; 14: 60–74.

Gilbert

Sun

Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials. J R Stat Soc C 2015; 64: 49–73.

Han

Sun

, et al. Mark-specific additive hazards regression with continuous marks. Lifetime Data Anal 2017; 23: 467–494.

Tibshirani

Regression shrinkage and selection via the lasso. J R Stat Soc B 1996; 58: 267–288.

Fan

Variable selection via nonconcave penalized likelihood and its oracle properties. J Am Stat Assoc 2001; 96: 1348–1360.

Zou

The adaptive Lasso and its oracle properties. J Am Stat Assoc 2006; 101: 1418–1429.

10.

Zhang

CH.

Nearly unbiased variable selection under minimax concave penalty. Ann Stat 2010; 38: 894–942.

11.

Fan

Lin H Zhou

Y. Local partial likelihood estimation for lifetime data. Ann Stat 2006; 34: 290–325.

12.

Wang

Huang

Variable selection in nonparametric varying-coefficient models for analysis of repeated measurements. J Am Stat Assoc 2008; 103: 1556–1569.

13.

Wang

Xia

Shrinkage estimation of the varying coefficient model. J Am Stat Assoc 2009; 104: 747–757.

14.

Yan

Huang

Model selection for cox models with time-varying coefficients. Biometrics 2012; 68: 419–428.

15.

Wei

Lu W Hao

H. Joint structure selection and estimation in the time-varying coefficient cox model. Stat Sinica 2016; 26: 547–567.

16.

Peng

Kutner

Shrinkage estimation of varying covariate effects based on quantile regression. Stat Comput 2014; 24: 853–869.

17.

Johnson

Long

Huang

, et al. Model selection and inference for censored lifetime medical expenditures. Biometrics 2015; 72: 731–741.

18.

Johnson

Lin

Zeng

Penalized estimating functions and variable selection in semiparametric regression models. J Am Stat Assoc 2008; 103: 672–680.

19.

Meinshausen

Bühlmann

High-dimensional graphs and variable selection with the lasso. Ann Stat 2006; 34: 1436–1462.

20.

Penalized regression: the bridge versus the LASSO. J Comput Graph Stat 1998; 7: 397–416.

21.

Zhang

Adaptive Lasso for Cox’s proportional hazards model. Biometrika 2007; 94: 691–703.

22.

Wang

Leng

Unified LASSO estimation via least squares approximation. J Am Stat Assoc 2007; 102: 1039–1048.

23.

Wyatt

Kwong

Desjardins

, et al. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998; 393: 705–711.

24.

Nickle

Heath

Jensen

, et al. Amino acid substitution matrices for HIV-1 subtype B. Technical Report, University of Washington, May 2005.

25.

Flynn

Forthal

Harro

, et al. Placebo-controlled phase 3 trial of recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 2005; 191: 654–665.

26.

Little

RJA

Rubin

DB.

Statistical analysis with missing data. New York: Wiley, 2002.

27.

Tian

Zucker

Wei

On the Cox model with time-varying regression coefficients. J Am Stat Assoc 2005; 100: 172–183.

28.

Belloni

Chernozhukov

Wang

Square-root LASSO: pivotal recovery of sparse signals via conic programming. Biometrika 2011; 98: 791–806.

29.

Martinussen

Scheike

TH.

Dynamic regression models for survival data. New York: Springer, 2006.

30.

Aalen

Johansen

An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat 1978; 5: 141–150.

31.

Pollard

Empirical processes: Theory and applications. Hayward, CA: Institute of Mathematical Statistics, 1990.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.19 MB

Variable selection for a mark-specific additive hazards model using the adaptive LASSO

Abstract

Keywords

Get full access to this article

References

Supplementary Material